Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system.

CONTEXT Reduced bone mineral density has been demonstrated among HIV-infected patients, but fracture prevalence is unknown. OBJECTIVE The objective of the study was to compare fracture prevalence in HIV-infected and non-HIV-infected patients. DESIGN This was a population-based study. SETTING The study was conducted at a large U.S. health care system. PATIENTS A total of 8525 HIV-infected and 2,208,792 non-HIV-infected patients with at least one inpatient or outpatient encounter between October 1, 1996, and March 21, 2008, was compared. MAIN OUTCOME MEASURE Fracture prevalence using specific International Classification of Diseases, Ninth Revision, Clinical Modification fracture codes was measured. RESULTS The overall fracture prevalence was 2.87 vs. 1.77 patients with fractures per 100 persons in HIV-infected, compared with non-HIV-infected patients (P < 0.0001). Among females, the overall fracture prevalence was 2.49 vs. 1.72 per 100 persons in HIV-infected vs. non-HIV-infected patients (P = 0.002). HIV-infected females had a higher prevalence of vertebral (0.81 vs. 0.45; P = 0.01) and wrist (1.31 vs. 0.83; P = 0.01) fractures per 100 persons, compared with non-HIV-infected females but had a similar prevalence of hip fractures (0.47 vs. 0.56; P = 0.53). Among males, the fracture prevalence per 100 persons was higher in HIV-infected vs. non-HIV-infected patients for any fracture (3.08 vs. 1.83; P < 0.0001), vertebral fractures (1.03 vs. 0.49; P < 0.0001), hip fractures (0.79 vs. 0.45; P = 0.001), and wrist fractures (1.46 vs. 0.99; P = 0.001). Fracture prevalence was higher relative to non-HIV-infected patients among African-American and Caucasian females and Caucasian males. CONCLUSIONS Fracture prevalence is increased in HIV-infected compared with non-HIV-infected patients.

[1]  S. Wallenstein,et al.  Risk factors for decreased bone density and effects of HIV on bone in the elderly , 2008, Osteoporosis International.

[2]  M. Díaz-Curiel,et al.  Evolution of bone mineral density in AIDS patients on treatment with zidovudine/lamivudine plus abacavir or lopinavir/ritonavir , 2008, HIV medicine.

[3]  S. Lawson-Ayayi,et al.  Reduced bone mineral density in HIV-infected patients: prevalence and associated factors , 2008, AIDS.

[4]  C. Vigouroux,et al.  Contribution of Mitochondrial Dysfunction and Oxidative Stress to Cellular Premature Senescence Induced by Antiretroviral Thymidine Analogues , 2008, Antiviral therapy.

[5]  S. Cummings,et al.  Long-term risk of incident vertebral fractures. , 2007, JAMA.

[6]  S. Walmsley,et al.  Fragility fractures and bone mineral density in HIV positive women: a case-control population-based study , 2007, Osteoporosis International.

[7]  S. Grinspoon,et al.  Effects of Weight, Body Composition, and Testosterone on Bone Mineral Density in HIV-Infected Women , 2007, Journal of acquired immune deficiency syndromes.

[8]  Y. Lo,et al.  Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection , 2007, AIDS.

[9]  T. Brown,et al.  Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review , 2006, AIDS.

[10]  J. Arnsten,et al.  HIV infection and bone mineral density in middle-aged women. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  B. Gage,et al.  Risk of osteoporotic fracture in elderly patients taking warfarin: results from the National Registry of Atrial Fibrillation 2. , 2006, Archives of internal medicine.

[12]  F. Sardanelli,et al.  Osteoporosis in HIV-infected subjects: a combined effect of highly active antiretroviral therapy and HIV itself? , 2005, Journal of acquired immune deficiency syndromes.

[13]  E. Shane,et al.  Bone mass and mineral metabolism in HIV+ postmenopausal women , 2005, Osteoporosis International.

[14]  J. Timpone,et al.  Reduced bone mineral density in human immunodeficiency virus-infected patients and its association with increased central adiposity and postload hyperglycemia. , 2004, The Journal of clinical endocrinology and metabolism.

[15]  Jeannie S. Huang,et al.  Reduced bone density in HIV-infected women , 2004, AIDS.

[16]  C. Baudoin,et al.  BMD Is Reduced in HIV‐Infected Men Irrespective of Treatment , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[17]  L. Bergoglio,et al.  Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy , 2003, AIDS.

[18]  K. Yarasheski,et al.  Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  N. Pocock,et al.  Bone mineral density abnormalities in patients with HIV infection. , 2002, Journal of acquired immune deficiency syndromes.

[20]  J Dequeker,et al.  Incidence of Vertebral Fracture in Europe: Results From the European Prospective Osteoporosis Study (EPOS) , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[21]  Jeannie S. Huang,et al.  Increased abdominal visceral fat is associated with reduced bone density in HIV-infected men with lipodystrophy , 2001, AIDS.

[22]  J. Eisman,et al.  Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy , 2001, AIDS.

[23]  G. Guaraldi,et al.  Pathological fractures in AIDS patients with osteopenia and osteoporosis induced by antiretroviral therapy. , 2001, AIDS.

[24]  K. Yarasheski,et al.  Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy , 2000, AIDS.